Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients
Journal
Journal of the Formosan Medical Association = Taiwan yi zhi
Journal Volume
121
Journal Issue
3
Pages
643 - 651
Date Issued
2022-03
Author(s)
Abstract
Decorin is a small leucine-rich proteoglycan rich in extracellular matrix with potential antitumor activity. However, the role of decorin in hematological malignancies remains unclear, especially in the case of multiple myeloma (MM), a bone marrow (BM) stroma-dependent plasma cell neoplasm.
Subjects
Decorin; Extracellular matrix; Hepatocyte growth factor; Mesenchymal stem cell; Myeloma
Type
journal article